Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sunhawk Vision BiotechROCO:7759 -0.16%20 Quick Ratio is 13.57 as of Jun. 2026, which is 53% below its 10-year median of 28.68. GuruFocus rates ROCO:7759 with a GF Score™ of 20/100. The stock has 1 warning sign investors should review. Among 1,409 Biotechnology companies, Sunhawk Vision Biotech ranks better than 85.73% on this metric.
Sunhawk Vision Biotech (ROCO:7759) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Sunhawk Vision Biotech Quick Ratio Related Terms
Sunhawk Vision Biotech Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:7759 vs VRTX, REGN, MRNA: Quick Ratio Comparison
For the Biotechnology subindustry, Sunhawk Vision Biotech's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sunhawk Vision Biotech Quick Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Sunhawk Vision Biotech's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Sunhawk Vision Biotech's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Sunhawk Vision Biotech's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sunhawk Vision Biotech (ROCO:7759) has a Quick Ratio of 13.57 as of Jun. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Sunhawk Vision Biotech and its competitors. This is 53% below median its historical median of 28.68. Over the past decade, Sunhawk Vision Biotech's Quick Ratio has ranged from 13.57 to 7,646.70. According to the industry distribution chart, Sunhawk Vision Biotech ranks #201 out of 1409 companies in the Biotechnology industry, placing it in the top 14.3%.
Is Sunhawk Vision Biotech's Quick Ratio too high?
Sunhawk Vision Biotech's current Quick Ratio of 13.57 is 53% below median its 10-year median of 28.68. Over the past 10 years, this metric has ranged from a low of 13.57 to a high of 7,646.70. The Biotechnology industry median Quick Ratio is 3.61. Sunhawk Vision Biotech's value of 13.57 is 275.9% above this industry median. Based on the distribution chart, Sunhawk Vision Biotech ranks #201 out of 1409 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Sunhawk Vision Biotech has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Sunhawk Vision Biotech's Quick Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Sunhawk Vision Biotech ranks #201 out of 1409 companies for Quick Ratio. This places Sunhawk Vision Biotech in the top 14% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 3.61. Sunhawk Vision Biotech's value of 13.57 is 275.9% above this benchmark. Historically, Sunhawk Vision Biotech's own Quick Ratio has ranged from 13.57 to 7,646.70 over the past decade. While the company's 10-year median is 28.68 vs. the industry median of 3.61, Sunhawk Vision Biotech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Biotechnology company?
The median Quick Ratio among Biotechnology companies is 3.61, based on 1,409 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sunhawk Vision Biotech's current Quick Ratio of 13.57 is 275.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Sunhawk Vision Biotech and its competitors. For the Biotechnology industry, the median Quick Ratio is 3.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sunhawk Vision Biotech's current Quick Ratio is 13.57, which is 53% below median its own 10-year median of 28.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunhawk Vision Biotech stock overvalued right now?
Sunhawk Vision Biotech (ROCO:7759) has a current Quick Ratio of 13.57. The current Quick Ratio is 13.57, which is 53% below median its 10-year median of 28.68 and 275.9% above the Biotechnology industry median of 3.61. Sunhawk Vision Biotech's overall GF Score™ is 20/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Sunhawk Vision Biotech (ROCO:7759), the current Quick Ratio is 13.57 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sunhawk Vision Biotech Inc is a biotechnology company. The company is focused on developing new solutions for eye health and vision care. The company specializes in research and development of cutting-edge technologies aimed at treating and preventing ocular diseases. Their product portfolio includes products and services for curing dry eyes, myopia, and corneal erosion.
20GF Score
Get the complete analysis for ROCO:7759
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7759 has been successfully added to your 
